Subclinical hypothyroidism and the risk of hypercholesterolemia

被引:135
作者
Hueston, WJ [1 ]
Pearson, WS [1 ]
机构
[1] Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA
关键词
hypothyroidism; mass screening; cholesterol;
D O I
10.1370/afm.79
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND Subclinical hypothyroidism, defined as a mild elevation in thyroid-stimulating hormone (TSH) levels in patients with normal serum thyroxine levels, has been associated with elevationed levels in serum cholesterol in some sample populations. These studies, however, have included referred patients and large numbers of patients with previously treated hyperthyroidism. The aim of this study was to assess whether subclinical hypothyroidism is associated with abnormal lipid levels in a population-based sample. METHODS Data from adults older than 40 years who did not previously have a diagnosis of hypothyroidism or who were taking thyroid replacement medication were analyzed from the National Health and Nutritional Examination Survey (NHANES) III. Subclinical hypothyroidism was defined as a TSH value of 6.7 to 14.9 mU/L and normal thyroxine (n = 215). Euthyroid control adults included participants with a TSH in a normal range between 0.36 and 6.7 mU/L (n = 8,013). Outcomes examined were serum cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride levels in those who had subclinical hypothyroidism and in euthyroid controls. RESULTS Persons meeting the criteria for subclinical hypothyroidism had higher mean cholesterol levels (226 vs 217 mg/dL, P =.003) and rates of elevated cholesterol levels (74.2% vs 63.9%, P = 0.02) than the euthyroid control group, but there were no significant differences in low-density lipoprotein (LDL) or high-density lipoprotein (HDL) levels. When adjusted for age, race, sex, and the use of lipid-lowering drugs, however, subclinical hypothyroidism was not related to elevations in cholesterol levels (adjusted odds ratio [OR] = 1.06, 95% confidence interval [CI], 0.57-1.97), LDL levels (adjusted OR = 0.89; 95% Cl, 0.59-1.35), or triglyceride levels (adjusted OR = 1.83; 95% Cl, 0.87-3.85) or to a low HDL level (adjusted OR = 0.94; 95% CI, 0.36-2.48). CONCLUSIONS Subclinical hypothyroidism does not appear to be associated with abnormalities in serum cholesterol or triglyceride levels when adjusted for confounding variables in this population-based study.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 21 条
[1]  
[Anonymous], 1996, GUID CLIN PREV SERV
[2]   The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534
[3]   L-THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
COOPER, DS ;
HALPERN, R ;
WOOD, LC ;
LEVIN, AA ;
RIDGWAY, EC .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) :18-24
[4]   Subclinical thyroid disease: A clinician's perspective [J].
Cooper, DS .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) :135-138
[5]   Screening for mild thyroid failure at the periodic health examination - A decision and cost-effectiveness analysis [J].
Danese, MD ;
Powe, NR ;
Sawin, CT ;
Ladenson, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (04) :285-292
[6]   Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature [J].
Danese, ND ;
Ladenson, PW ;
Meinert, CL ;
Powe, NR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :2993-3001
[7]   SUBCLINICAL HYPOTHYROIDISM - TO TREAT OR NOT TO TREAT, THAT IS THE QUESTION [J].
FRANKLYN, J .
CLINICAL ENDOCRINOLOGY, 1995, 43 (04) :443-444
[8]  
GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015
[9]  
Helfand M, 1998, ANN INTERN MED, V129, P141, DOI 10.7326/0003-4819-129-2-199807150-00020
[10]  
Helfand M, 1998, ANN INTERN MED, V129, P144, DOI 10.7326/0003-4819-129-2-199807150-00020